Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 110 clinical trials
Growth Hormone as a Model for Reversible Activation of Adipose Tissue Fibrosis

Background: Adipose tissue fibrosis denotes excessive pathological accumulation of extracellular matrix (ECM) in adipose tissue and is a marker of dysfunction. Growth hormone (GH) activates

  • 15 views
  • 10 Sep, 2021
  • 1 location
A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism

This clinical trial will use growth hormone as a novel treatment for Phelan-McDermid syndrome (PMS) and idiopathic autism. A double-blind, placebo-controlled crossover trial design will be used

  • 0 views
  • 10 Aug, 2022
PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency. (OraGrowtH212)

The goals of this single site trial are to study the pharmacokinetics (PK) and pharmacodynamics of LUM-201 and effects of LUM-201 administration on growth hormone release over time in children

  • 0 views
  • 23 Jul, 2022
  • 1 location
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

. Growth hormone is a hormone produced in the pituitary gland that helps regulate metabolism and growth. Individuals with obesity, on average, secrete less growth hormone than individuals without obesity

hepatic failure
liver disease
body mass index
fatty liver
MRI
  • 3 views
  • 18 Feb, 2022
Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy

Patients with a history of mild traumatic brain injury (mTBI) or post acute sequelae of SARS-CoV-2 (PASC) and abnormal growth hormone secretion, as measured by glucagon stimulation test, will be

somatropin
hormone therapy
Accepts healthy volunteers
traumatic brain injury
post-concussion syndrome
  • 111 views
  • 13 May, 2022
  • 1 location
A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy

Acromegaly is a disease characterized by excess growth hormone(GH) and insulin like growth factor(IGF)-1. Pituitary GH secreting adenoma is the major cause of acromegaly. Acromegalic

cardiomyopathy
somatostatin
growth factor
heart failure
insulin
  • 692 views
  • 25 Jan, 2021
  • 1 location
Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial (TRIIM-X)

, cardiovascular disease, diabetes, dementia, and also infectious diseases, including flu and COVID-19. The study uses multiple agents in combination with personalized doses of recombinant human growth

Accepts healthy volunteers
  • 161 views
  • 05 Mar, 2022
  • 1 location
Evaluating the Impact of Focused Muscle Contraction Therapy in U.S. Veterans

This research study is being done to investigate if the GH Method exercise program positively affects body composition, improves physical abilities and can improve the overall sense of wellbeing

depressed mood
symptoms of stress
  • 0 views
  • 31 Oct, 2021
  • 1 location
Evaluating the Impact of Focused Muscle Contraction Therapy in Retire APF Players

occur at UIC. All exercise intervention training visits will occur at Gh Fitlab.

chronic pain
growth hormone
  • 0 views
  • 03 Jul, 2021
  • 1 location
Behavioral Therapy in Patients With Rumination

physiotherapy to relax tensed abdominal and thoracic muscles. Before referral to the study, gastroscopy, esophageal hgh-resolution manometry and 24-hour esophageal pH and impedance monitoring are

anxiety
  • 0 views
  • 11 Mar, 2022
  • 1 location